News
2h
Zacks Investment Research on MSNVeeva vs. Salesforce: Which Life Sciences CRM Stock Is the Better Buy?
A significant shift is underway in the enterprise software landscape, particularly within the life sciences customer relationship management (CRM) market. Veeva Systems VEEV, a long-time partner of ...
On a bustling trading day, Salesforce (CRM) witnessed a significant drop in trading volume, down 25.5% to $1.315 billion, landing it at 62nd in the daily rankings. Despite the dip, the company's stock ...
This US-listed growth stock offers exposure to an exciting new industry. And Edward Sheldon sees a huge amount of investment potential. The post Could buying this S&P 500 growth stock be like ...
Salesforce's trading volume exploded on July 21, 2025, hitting 1.759 billion. It ranked 35th for the day, even as the stock ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
The DJIA is in positive territory thus far in 2025. The Dow Jones Industrial Average (DJINDICES: ^DJI) is up nearly 5% so far ...
Salesforce, Inc. (NYSE:CRM) is one of the Trending AI Stocks in Focus This Week. On July 16, Citizens JMP analyst Patrick Walravens reiterated a “Market Outperform” rating on the stock with a $430.00 ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
BofA maintained its Buy rating on Salesforce (NYSE:CRM) while taking a deep dive into the company's largest business, Service ...
If you missed the boat on Palantir (NASDAQ:PLTR) stock’s incredibly multi-bagger surge over the past year and aren’t remotely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results